Blood Gas And Electrolyte Analyzers Market is estimated to reach USD 653.5 million by 2022. An increase in demand for blood gas testing, growing incidence among the patients in emergency departments and critical care, increasing healthcare expenditure, increase in the change of focus towards point-of-care testing and introduction of new expertise are some of the most affecting drivers of this market.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/blood-gas-electrolyte-analyzers-market/request-sample
The key driving factors responsible for the growth of Blood Gas And Electrolyte Analyzers market :
Increase in the base population will also contribute towards the growth of the market in the coming years by resulting in high occurrence rates of diseases which include cancer, respiratory disorders, diabetes, and heart-related diseases. Furthermore, the appearance of multi-parameter monitoring device which helps in increasing test menus and rise in requirement for miniaturized devices which is expected to improve market growth over the coming period. For example, according to the WHO, the global geriatric population of 65 years and above will help to rise from 7% in 2000 to 16% in 2050. For cancer and other chronic diseases, aging is one of the risk factors and therefore, the global aging population will help to increase its market growth.
Product Insights
Portable analyzers and benchtop are key product categorization of the electrolyte and blood gas segment. Benchtop analyzers with a display (LCD) are larger, with a keypad to enter information and also contains a slot for placing in a sample tube or test strip, while portable analyzers are movable thus facilitating bedside examination. In 2016, the portable analyzers market held the major share at over 62%. Portable analyzers have many advantages which includes automation of tasks, portability and ease-of-use, decreased manual errors, self-assessing ability and low maintenance which are estimated to act as key drivers contributing to increase in the growth of the market share.
Application Insights
In 2016, combined analyzers conquered the overall market due to the occurrence of broad product portfolio with large test volumes. The combined analyzer market is anticipated to witness an increase in growth as a result of increasing need for analyzers which need less maintenance, further facilitating the test results for electrolyte and blood count from samples such as whole dialysate, urine, blood, serum, and plasma.
End-use Insights
The market is divided on the basis of end-use into central laboratories and point-of-care. The point-of-care division is identified to be the best growing segment in the coming years. The key contributing factor is the continuous technological improvements, thus attracting end-users to move focus towards point-of-care analysers.
Special importance is given to cardiothoracic surgical departments, followed by emergency transport systems, and critical care departments as designated by a large volume of systems. The increase in demand for point-of-care blood gas and electrolyte analysers is expected to growth over the forecast period. These devices facilitate automated sample handling which helps to trim down the associated errors along with providing user variability. The aforementioned factors are expected to help these devices to achieve high preference matrix among the consumers.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/blood-gas-electrolyte-analyzers-market
The global Blood Gas and Electrolyte Analyzers Market is estimated to reach USD 653.5 million by 2022.
An increase in demand for blood gas testing, growing incidence among the patients in emergency departments and critical care, increasing healthcare expenditure, increase in the change of focus towards point-of-care testing and introduction of new expertise are some of the most affecting drivers of this market.Increase in the base population will also contribute towards the growth of the market in the coming years by resulting in high occurrence rates of diseases which include cancer, respiratory disorders, diabetes, and heart-related diseases.
Furthermore, the appearance of multi-parameter monitoring device which helps in increasing test menus and rise in requirement for miniaturized devices which is expected to improve market growth over the coming period.
For example, according to the WHO, the global geriatric population of 65 years and above will help to rise from 7% in 2000 to 16% in 2050.
Benchtop analyzers with a display (LCD) are larger, with a keypad to enter information and also contains a slot for placing in a sample tube or test strip, while portable analyzers are movable thus facilitating bedside examination.
The combined analyzer market is anticipated to witness an increase in growth as a result of increasing need for analyzers which need less maintenance, further facilitating the test results for electrolyte and blood count from samples such as whole dialysate, urine, blood, serum, and plasma.End-use InsightsThe market is divided on the basis of end-use into central laboratories and point-of-care.
The Global Blood Gas and Electrolyte Analyzer Market size is estimated to be USD 3.57 Billion in 2019 and is predicted to reach USD 6.24 Billion by 2030 with a CAGR of 5.2% from 2020-2030.The blood gas and electrolyte analyzer is a medical device used to detect diabetes, blood vessel hemorrhage, drug overdose and shock.
It also determines the abnormal metabolite & levels of electrolytes in blood along with the levels of oxygen/carbon dioxide exchange and the pH balance.
Blood gas analyzers are utilized to test several parameters including O2 concentration, hydrogen ion and others.Top Companies: Radiometer Medical Aps (A Subsidiary of Danaher Corporation), Instrumentation Laboratory (A Werfen Company), Siemens AG, Roche Diagnostics Limited, Abbott Laboratories, Inc., Nova Biomedical, OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.), ERBA Diagnostics Mannheim GmbH, Medica Corporation and Alere, Inc and others.Access Full Description of this report at:-https://www.nextmsc.com/report/blood-gas-and-electrolyte-analyzer-market Blood gas and electrolyte analyzer market report is segmented on the basis of type, product/ brand, end user and geography.
Based on end users, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and others.
Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.The consistent upsurge in the elderly population has lead to upsurge in number of patients in emergency departments, critical care units and operating rooms receiving critical care.
According to WHO the global population of the age group 65 years and above is estimated to increase to 16% by 2050 which further assures the market growth.
According to research report the Blood Gas and Electrolyte Analyzer Market was estimated to be USD 506.9 Million in 2016, which would reach USD 636 Million by 2021, growing at a CAGR of 4.6% during 2016 to 2021.Ask For Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963A number of factors, such as the growing number of patients being treated in ICUs, NICUs, and emergency departments, and the increasing adoption of technologically advanced biosensors and data analysis software for developing next-generation blood gas analyzers are expected to drive the growth of the blood gas analyzer market in the coming years.
The other factors driving the growth of Blood Gas and Electrolyte Analyzer Market include rising geriatric population and the subsequent increase in the prevalence of chronic diseases, increasing adoption of technologically advanced biosensors and data analysis software, growing demand for technology integrated combined systems, and miniaturization of POC blood gas analyzers.North America is expected to account for the largest blood gas analyzer market share in 2016, which is primarily attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives in this region.
However, the APAC Blood Gas Analyzers market is projected to witness a higher growth during the forecast period due to the growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures.The Blood Gas and Electrolyte Analyzer Market is segmented on the basis of major product brands (i-STAT, epoc, GEM 3000, GEM 3500, GEM 4000, ABL800, ABL80, ABL90, cobas b 221, cobas b 121, cobas b 123, RAPID Series) in four major regional segments, namely, North America, Europe, APAC, and Rest of the World.
This report analyzes the market from both value and volume perspectives.
GEM 3000 is expected to account for the largest share of the global blood gas analyzers market in 2016.
This is mainly because GEM 3000 delivers real-time system diagnostics, requires low labor-intensive system calibration, and eliminates lengthy equipment training and possible human errors.
